Skip to main content

Table 1 PD-1 and PD-L1 status of prostate cancer cases and BPH controls (IMC)

From: The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer

 

PCa, n = 96 (%)

BPH, n = 44 (%)

X2

P

PD-1 epithelial positive (%)

2 (2.1)

1 (2.2)

0.000

1.000

PD-L1 epithelial positive (%)

24 (25.0)

2 (4.5)

7.050

0.008

PD-1 lymphocytes positive (%)

13 (13.5)

2 (4.5)

1.899

0.192

PD-L1 lymphocytes positive (%)

26 (27.1)

5 (11.4)

4.325

0.038

  1. PD-1 programmed cell death protein 1, PD-L1 programmed death-ligand 1